Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1799782
rs1799782
0.010 GeneticVariation BEFREE In conclusion, our study has shown that XRCC1 Gln399Arg, XRCC1 Arg194Trp, XRCC3 Thr241Met and ERCC5 Asp1558His are associated with risk of gliomas and meningiomas. 23534771

2013

dbSNP: rs7574920
rs7574920
XDH
0.010 GeneticVariation BEFREE Furthermore, the same GPX1 polymorphisms and XDH rs7574920 were found to significantly modify the association between cumulative lead exposure and meningioma. 19505917

2009

dbSNP: rs730882035
rs730882035
VHL
0.010 GeneticVariation BEFREE We describe a Sicilian girl with type 2C VHL who showed the apparently de novo mutation R161Q in association with an extra-axial supratentorial frontal meningioma, which can be included as a characteristic sign in VHL. 17102087

2006

dbSNP: rs768803947
rs768803947
0.010 GeneticVariation BEFREE A tumor-specific missense mutation as a result of an A-to-G transition with an Asn204Ser change was found in one meningioma that nevertheless retained the normal allele. 11520574

2001

dbSNP: rs2736100
rs2736100
0.010 GeneticVariation BEFREE Three out of the eight evaluated LTL SNPs were significantly associated with increased meningioma risk (rs10936599: OR 1.14, 95% CI 1.01-1.28, rs2736100: OR 1.13, 95% CI 1.03-1.25, rs9420907: OR 1.22, 95% CI 1.07-1.39). 30796745

2019

dbSNP: rs202247756
rs202247756
0.010 GeneticVariation BEFREE We combined genome-wide linkage analysis and exome sequencing, and we identified in suppressor of fused homolog (Drosophila), SUFU, a c.367C>T (p.Arg123Cys) mutation segregating with the meningiomas in the family. 22958902

2012

dbSNP: rs9420907
rs9420907
0.010 GeneticVariation BEFREE Three out of the eight evaluated LTL SNPs were significantly associated with increased meningioma risk (rs10936599: OR 1.14, 95% CI 1.01-1.28, rs2736100: OR 1.13, 95% CI 1.03-1.25, rs9420907: OR 1.22, 95% CI 1.07-1.39). 30796745

2019

dbSNP: rs699473
rs699473
0.010 GeneticVariation BEFREE We observed increased risk of glioma (odds ratio [OR](CT/CC)=1.3; 95% confidence interval [95% CI], 1.0-1.7) and meningioma (OR(CT/CC)=1.7; 95% CI, 1.1-2.7) with the C variant of SOD3 rs699473. 18682580

2008

dbSNP: rs121918347
rs121918347
SMO
0.010 GeneticVariation BEFREE A subset of meningiomas lacking NF2 alterations harbored recurrent oncogenic mutations in AKT1 (p.Glu17Lys) and SMO (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways. 23334667

2013

dbSNP: rs662
rs662
0.010 GeneticVariation BEFREE The frequencies of the PON1 genotypes and allelic variants of the polymorphisms PON1 L55M and PON1 Q192R did not differ significantly between patients with astrocytoma and meningioma and controls. 20723250

2010

dbSNP: rs854560
rs854560
0.010 GeneticVariation BEFREE The frequencies of the PON1 genotypes and allelic variants of the polymorphisms PON1 L55M and PON1 Q192R did not differ significantly between patients with astrocytoma and meningioma and controls. 20723250

2010

dbSNP: rs25406
rs25406
0.010 GeneticVariation BEFREE Significantly increased meningioma risk was also observed for the minor allele variants of ERCC4 rs1800067 (P(trend) .01); MUTYH rs3219466 (P(trend) .02), and PCNA rs25406 (P(trend) .03). 20150366

2010

dbSNP: rs150766139
rs150766139
0.010 GeneticVariation BEFREE The carrier of c.268C>T (p.Q90*) and 550-1G>A was diagnosed with CRC and meningioma at ages 37 and 45 respectively, being reclassified as attenuated adenomatous polyposis after the cumulative detection of 26 adenomas. 31227763

2019

dbSNP: rs121434259
rs121434259
NF2
T 0.700 CausalMutation CLINVAR

dbSNP: rs587776563
rs587776563
NF2
G 0.700 CausalMutation CLINVAR

dbSNP: rs1805794
rs1805794
NBN
0.010 GeneticVariation BEFREE The NBN rs1805794 minor allele variant was associated with decreased meningioma risk (P(trend) .006). 20150366

2010

dbSNP: rs10936599
rs10936599
0.010 GeneticVariation BEFREE Three out of the eight evaluated LTL SNPs were significantly associated with increased meningioma risk (rs10936599: OR 1.14, 95% CI 1.01-1.28, rs2736100: OR 1.13, 95% CI 1.03-1.25, rs9420907: OR 1.22, 95% CI 1.07-1.39). 30796745

2019

dbSNP: rs3219466
rs3219466
0.010 GeneticVariation BEFREE Significantly increased meningioma risk was also observed for the minor allele variants of ERCC4 rs1800067 (P(trend) .01); MUTYH rs3219466 (P(trend) .02), and PCNA rs25406 (P(trend) .03). 20150366

2010

dbSNP: rs1801394
rs1801394
0.020 GeneticVariation BEFREE Moreover, we found that MTRR A66G (rs1801394) variant genotypes was associated with increased risk of meni</span>ngioma and glioma (G vs. A: OR=1.11, P=0.020; GG vs. AA+AG: OR=1.17, P=0.043; GG vs. AA: OR=1.22, P=0.023). 28915669

2017

dbSNP: rs1801394
rs1801394
0.020 GeneticVariation BEFREE Our updated meta-analysis provided statistical evidence for the role of <i>MLLT10</i> rs12770228, <i>MTRR</i> rs1801394, and <i>MTHFR</i> rs1801131 in increased susceptibility to meningioma. 28405167

2017

dbSNP: rs1217691063
rs1217691063
0.020 GeneticVariation BEFREE The current meta-analysis firstly provides evidence that the MTHFR C677T polymorphism may modify the risk for brain tumors, particularly meningioma. 23846816

2013

dbSNP: rs1217691063
rs1217691063
0.020 GeneticVariation BEFREE C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas. 16821630

2006

dbSNP: rs1801131
rs1801131
0.020 GeneticVariation BEFREE Our updated meta-analysis provided statistical evidence for the role of <i>MLLT10</i> rs12770228, <i>MTRR</i> rs1801394, and <i>MTHFR</i> rs1801131 in increased susceptibility to meningioma. 28405167

2017

dbSNP: rs1801131
rs1801131
0.020 GeneticVariation BEFREE In conclusion, our meta-analysis suggests that two folate metabolism genetic variants MTRR A66G (rs1801394) and MTHFR A1298C (rs1801131) contribute to genetic susceptibility to meningioma and glioma in adults. 28915669

2017

dbSNP: rs397507444
rs397507444
0.010 GeneticVariation BEFREE In conclusion, our meta-analysis suggests that two folate metabolism genetic variants MTRR A66G (rs1801394) and MTHFR A1298C (rs1801131) contribute to genetic susceptibility to meningioma and glioma in adults. 28915669

2017